Head-to-head · WeighScore
TeleZen MD vs Trimrose
The verdict
TeleZen MD takes it — 60.4/100 to 55.4/100.
TeleZen MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleZen MD (telezenmd.com) is a 100% online U.S.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | TeleZen MD | Trimrose |
|---|---|---|
| WeighScore | 60.4/100 | 55.4/100 |
| Grade | C | C |
| Scorecard rank | #324 | #440 |
| Semaglutide | $198/mo (compounded) | Not disclosed |
| Tirzepatide | $298/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #324 · C
Strengths
- Says it serves all 50 states — among the broadest claimed reach in the compounded segment
- Markets U.S.-based, FDA-registered pharmacies
- $100 off your first order with code WELCOME100
- Fully online U.S. telehealth model with physician evaluation
- Education-forward, physician-led positioning
Where it loses points
- Partner pharmacy not named
- Legal entity name and state of incorporation not disclosed
- Brand-name medications not addressed on the homepage
- LegitScript certification not confirmed
- All-50-states claim is the provider's own, not independently verified
Graded #440 · C
Strengths
- Free, no-cost, no-obligation online eligibility quiz before any commitment
- Offers a choice of a weekly compounded GLP-1 injection or a daily oral option
- Fully online — assessment, provider review, and home delivery with ongoing support
Where it loses points
- Runs on the CareValidate white-label platform and isn't the medical provider itself — a support@carevalidate.com address is exposed on the site
- Pricing isn't shown publicly; the cost and the specific compounded molecule appear only after you complete the eligibility quiz
- The states served, pharmacy partner and any LegitScript/503A certification aren't disclosed on the public site
- Markets 'up to 22.5% of body weight' — a trial figure for branded tirzepatide, not a guaranteed or compounded-specific outcome
- Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.